Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-05T14:43:52.955Z Has data issue: false hasContentIssue false
  • English
  • Français

Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms

Published online by Cambridge University Press:  04 November 2004

B. O. L. DUKE
B. O. L. DUKE
Affiliation:
River Blindness Foundation, 2 Hillside, Lancaster LA1 1YH, UK
Get access Rights & Permissions [Opens in a new window]

Abstract

During a 3-year trial of the effects of ivermectin (MectizanR) on adult worms and microfilariae of Onchocerca volvulus in the Republic of Cameroon, comparison was made between the percentages of calcified and uncalcified moribund (M) and dead (D) adult female worms dying following (a) the standard dose (150 μg/kg) given annually; (b) high doses (400, then 800 μg/kg) given annually; and (c and d) these same doses given at 3-monthly intervals. In the killing of adult female O. volvulus worms, the relative rôles of (a) natural causes; (b) a presumed, direct, anthelminthic, macrofilaricidal action of ivermectin; and (c) a potentially fatal pleomorphic ovarian neoplasm (PN), of which the incidence is increased by ivermectin treatment, are herein further investigated and discussed. It is concluded that ivermectin per se has a considerable direct macrofilaricidal action against female worms and that this lethal effect is supplemented by the drug's ability in some worms to increase the incidence, and the spread throughout the body of the worm, of the potentially fatal PN ovarian tumour. In moribund and dead ivermectin-treated female worms that were heavily invaded by PN, it is probable that the neoplasm was chiefly responsible for their death, but the additional direct anthelminthic action of the drug, which by itself has been responsible for the death of many other female worms, cannot be excluded as having played a supplementary lethal rôle. Similar problems as to the exact means by which adult female worms are killed may arise now that ivermectin is used in Africa for the mass treatment of lymphatic filariasis; or if and when the macrofilaricidal actions on O. volvulus of other drugs, which are closely related to ivermectin, come to be investigated.

Keywords

Onchocerca volvulusivermectinpleomorphic neoplasmmacrofilaricidesCameroon
Type
Research Article
Information
Parasitology , Volume 130 , Issue 4 , April 2005 , pp. 447 - 453
Copyright
2004 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

AWADZI, K., OPOKU, N. O., ADDY, E. T. & QUARTEY, B. T. ( 1995). The chemotherapy of onchocerciasis XIX: the clinical and laboratory tolerance of high dose ivermectin. Tropical Medicine and Parasitology 46, 131–137.Google Scholar
AWADZI, K., OPOKU, N. O., ATTAH, S. K., ADDY, E. T., DUKE, B. O. L., NYAME, P. K. & KSHIRSAGAR, N. A. ( 1997). The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment. Annals of Tropical Medicine and Parasitology 91, 281–296.CrossRefGoogle Scholar
BÜTTNER, D. W., ALBIEZ, E. J., VON ESSEN, J. & ERICHSEN, J. ( 1988). Histological examination of adult Onchocerca volvulus and comparison with the collagenase technique. Tropical Medicine and Parasitology 39, 390–417.Google Scholar
DUKE, B. O. L., MARTY, A. M., PEET, D. L., GARDON, J., PION, S. D. S., KAMGNO, J. & BOUSSINESQ, M. ( 2002). Neoplastic change in Onchocerca volvulus and its relation to ivermectin treatment. Parasitology 125, 431–444.CrossRefGoogle Scholar
DUKE, B. O. L., ZEA-FLORES, G. & GANNON, R. T. ( 1990). On the reproductive activity of the female Onchocerca volvulus. Tropical Medicine and Parasitology 41, 387–402.CrossRefGoogle Scholar
FOBI, G., GARDON, J., KAMGNO, J., AIMARD-FAVENAC, L., LAFLEUR, C., GARDON-WENDEL, N., DUKE, B. O. L. & BOUSSINESQ, M. ( 2005). A randomised, double-blind controlled trial of the effects of ivermectin at normal and high doses, given annually or 3-monthly, against Onchocerca volvulus: ophthalmological results. Transactions of the Royal Society of Tropical Medicine and Hygiene 99 (in the Press).CrossRefGoogle Scholar
GARDON, J., BOUSSINESQ, M., KAMGNO, J., GARDON-WENDEL, N., DEMANGA-NGANGUE & DUKE, B. O. L. ( 2002). Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet 360, 203–210.CrossRefGoogle Scholar
KAMGNO, J., GARDON, J., GARDON-WENDEL, N., DEMANGA-NGANGUE, DUKE, B. O. L. & BOUSSINESQ, M. ( 2004). Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly. Transactions of the Royal Society of Tropical Medicine and Hygiene 98, 496–504.CrossRefGoogle Scholar
NEAFIE, R. C., MARTY, A. M. & DUKE, B. O. L. ( 2000). Onchocerciasis. In Pathology of Infectious Diseases I, Helminthiases ( ed. Meyers, W. M.), pp. 287–306. Armed Forces Institute of Pathology, American Registry of Pathology, Washington D.C.
SCHULZ-KEY, H. ( 1988). The collagenase technique: how to isolate and examine adult Onchocerca volvulus for the evaluation of drug effects. Tropical Medicine and Parasitology 39, 423–440.Google Scholar
SCHULZ-KEY, H. & KARAM, M. ( 1984). Quantitative assessment of microfilariae and adults of Onchocerca volvulus in ethanol-fixed biopsies and nodules. Transactions of the Royal Society of Tropical Medicine and Hygiene 78, 157–159.CrossRefGoogle Scholar